Repatha (evolocumab) is a PCSK9 inhibitor for lowering LDL cholesterol. It currently comes in one form: the SureClick Autoinjector pen. The Pushtronex on-body infusor was discontinued in June 2024 and ...
Credit: Amgen. The Repatha Pushtronix System will be discontinued as of June 30, 2024. Amgen has announced that the Repatha (evolocumab) Pushtronix ® System (single-dose on-body infusor with prefilled ...
Yes, Repatha is still available as a medication used to help lower “bad” LDL cholesterol and reduce the risk of serious heart problems. However, while the medication itself is still available, the way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results